LUMO Historical PE Ratio image   This LUMO PE ratio history page last updated 11/15/2022
LUMO Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q3 2022
11/14/2022
5.82-0.86-3.44NA
Q2 2022
8/9/2022
8.10-0.94-3.76NA
Q1 2022
5/10/2022
8.05-0.92-3.68NA
Q4 2021
3/10/2022
9.52-0.68-2.72NA
Q3 2021
11/3/2021
10.04-0.90-3.60NA
Q2 2021
8/5/2021
7.57-1.04-4.16NA
Q1 2021
5/5/2021
10.50-1.04-4.16NA
Q4 2020
3/9/2021
12.93-0.31-1.24NA
Q3 2020
11/10/2020
14.560.210.8417.3
Q2 2020
8/13/2020
15.41-0.65-2.60NA
Q1 2020
5/28/2020
14.50-0.14-0.56NA
LUMO PE History Chart
PeriodPriceGAAPTTMPE
Q3 2022
11/14/2022
5.82-0.86-3.40NA
Q2 2022
8/9/2022
8.10-0.94-3.44NA
Q1 2022
5/10/2022
8.05-0.92-3.54NA
Q4 2021
3/10/2022
9.52-0.68-3.66NA
Q3 2021
11/3/2021
10.04-0.90-3.29NA
Q2 2021
8/5/2021
7.57-1.04-2.18NA
Q1 2021
5/5/2021
10.50-1.04-1.79NA
Q4 2020
3/9/2021
12.93-0.31-0.89NA
Q3 2020
11/10/2020
14.560.21NANA
Q2 2020
8/13/2020
15.41-0.65NANA
Q1 2020
5/28/2020
14.50-0.14NANA
Quotes delayed 20 minutes

Email EnvelopeFree LUMO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Lumos Pharma (LUMO) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

LUNG PE Ratio History
LXRX PE Ratio History
LYEL PE Ratio History
LYRA PE Ratio History
MACK PE Ratio History
MASI PE Ratio History
MBIO PE Ratio History
MBOT PE Ratio History
MBRX PE Ratio History
MCK PE Ratio History
How should the LUMO historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Lumos Pharma. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this LUMO Historical PE Ratio page.

What is the average historical PE for LUMO based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The LUMO historical PE ratio using the annualized quarterly earnings method works out to 17.3.

What is the average historical PE for LUMO based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The LUMO historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the LUMO Historical PE Ratio information for Lumos Pharma' stock. The average LUMO historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 17.3. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average LUMO historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this LUMO historical PE result, against the recent PE: when this page was posted on 11/14/2022, the most recent closing price for LUMO had been 5.82, and the most recent quarterly earnings result, annualized, was 0.84. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent LUMO PE on 11/14/2022 based on annualized quarterly EPS was 6.9. Based on LUMO's history, that recent PE is low relative to the historical average, with the recent PE 60.1% lower than the historical average PE across our data set for Lumos Pharma.

For self directed investors doing their due diligence on LUMO or any other given stock, valuation analysis for LUMO can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Lumos Pharma PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for LUMO. Thanks for visiting, and the next time you need to research LUMO Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: BRKB Videos, DNR YTD Return, Top Ten Hedge Funds Holding BAP.

 

LUMO Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.